Epigenetics and autoimmunity, with special emphasis on methylation.

Area of Science:

• Immunology
• Epigenetics
• Molecular Biology

Background:

• Epigenetics involves heritable gene expression changes without altering DNA sequence.
• Emerging evidence links epigenetic modifications to the development of autoimmune diseases.
• DNA methylation is a key epigenetic mechanism implicated in immune cell function.

Purpose of the Study:

• To explore the role of epigenetic alterations, particularly DNA methylation, in autoimmune disorders.
• To investigate the potential of reversing epigenetic changes for therapeutic benefit in autoimmunity.

Main Methods:

• Inhibition of DNA methyltransferases (DNMTs) in animal models to study autoimmunity induction.
• Analysis of DNA methylation patterns in immune cells from patients with systemic lupus erythematosus (SLE), rheumatoid arthritis, and multiple sclerosis.
• Assessment of gene expression changes, cell cycle progression, and pathway activation (e.g., Erk pathway) in relation to DNA methylation status.
• Investigating the reversibility of epigenetic changes through targeted interventions, such as blocking interleukin-6 signaling.

Main Results:

• DNMT inhibition in animals can induce systemic lupus erythematosus (SLE).
• Monozygotic twins discordant for SLE exhibit differences in DNA methylation.
• Defects in DNA methylation are observed in lymphocytes from SLE patients, synoviocytes from rheumatoid arthritis patients, and neural cells from multiple sclerosis patients.
• DNA hypomethylation in SLE T and B cells correlates with reduced DNMT efficacy and altered histone acetylation.
• Demethylation can lead to the transcription of genes involved in inflammation and immune responses.
• These epigenetic changes are potentially reversible, as demonstrated by the restoration of DNA methylation status upon blockade of the interleukin-6 autocrine loop in SLE B cells.

Conclusions:

• Epigenetic dysregulation, particularly DNA hypomethylation, plays a significant role in the pathogenesis of autoimmune diseases.
• Reversing epigenetic alterations, such as restoring DNA methylation patterns, represents a promising therapeutic avenue for autoimmune disorders.
• Targeting specific molecular pathways, like the interleukin-6 loop, can modulate epigenetic status and offer new treatment strategies.